Journal article
Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies
Abstract
Lê LH, Swenerton KD, Elit L, Provencher DM, Stuart GCE, Le T, Lee U, Rodgers A, Pond GR, Oza AM. Phase II multicenter openlabel study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies. Int J Gynecol Cancer 2005;15:799–806. The results of a multicenter phase II study investigating carboplatin and pegylated liposomal doxorubicin (PLD) in patients with recurrent/metastatic uterine and cervical malignancies …
Authors
Lê LH; Swenerton KD; Elit L; Provencher DM; Stuart GCE; Le T; Lee U; Rodgers A; Pond GR; Hu H
Journal
International Journal of Gynecological Cancer, Vol. 15, No. 5, pp. 799–806
Publisher
Elsevier
Publication Date
9 2005
DOI
10.1136/ijgc-00009577-200509000-00014
ISSN
1048-891X